» Articles » PMID: 27533464

Comprehensive N-glycan Profiles of Hepatocellular Carcinoma Reveal Association of Fucosylation with Tumor Progression and Regulation of FUT8 by MicroRNAs

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Aug 18
PMID 27533464
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Glycosylation has significant effects on cancer progression. Fucosylation is one of the most important glycosylation events involved in hepatocellular carcinoma (HCC). Here, we compared N-glycan profiles of liver tumor tissues and adjacent tissues of 27 HCC patients to reveal the association between fucosylation and HCC progression, as well as verified the potential role of miRNA in regulating fucosylation. Mass spectrometry (MS) analysis showed pronounced differences of the N-glycosylation patterns and fucosylated N-glycans between the adjacent and tumor tissues. Different fucosyltransferase (FUT) genes were also identified in adjacent and tumor tissues, and two HCC cell lines with different metastatic potential. High-level expression of FUT8 was detected in tumor tissues and highly metastatic HCC cells. Altered levels of FUT8 in HCC cell lines significantly linked to the malignant behaviors of proliferation and invasion in vitro. Furthermore, using microRNA array, we identified FUT8 as one of the miR-26a, miR-34a and miR-146a-targeted genes. An inverse correlation was revealed between the expression levels of FUT8 and these miRNAs. Luciferase reporter assay demonstrated these miRNAs specifically interacted with the 3'UTR of FUT8 and subsequently down-regulated FUT8 expression-level. The forced expression of these miRNAs was able to induce a decrease in FUT8 levels and thereby to suppress HCC cells progression. Altogether, our results indicate that fucosylated N-glycan and FUT8 levels can be used as markers for evaluating HCC progression, as well as miRNAs may be involved in inhibition of fucosylation machinery through targeting FUT8.

Citing Articles

Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma.

Wang M, Grauzam S, Bayram M, Dressman J, DelaCourt A, Blaschke C Commun Med (Lond). 2024; 4(1):258.

PMID: 39627514 PMC: 11614901. DOI: 10.1038/s43856-024-00677-7.


Roles of core fucosylation modification in immune system and diseases.

Pan Q, Zhang X Cell Insight. 2024; 4(1):100211.

PMID: 39624801 PMC: 11609374. DOI: 10.1016/j.cellin.2024.100211.


Stable overexpression of native and artificial miRNAs for the production of differentially fucosylated antibodies in CHO cells.

Schlossbauer P, Naumann L, Klingler F, Burkhart M, Handrick R, Korff K Eng Life Sci. 2024; 24(6):2300234.

PMID: 38845814 PMC: 11151017. DOI: 10.1002/elsc.202300234.


LncRNA PART1 promotes malignant biological behaviours associated with head and neck cancer cells via synergistic action with FUT6.

Yao Y, Zhang Y, Shi J, Xu X, Gao Y, Bai S Cancer Cell Int. 2024; 24(1):185.

PMID: 38807207 PMC: 11134962. DOI: 10.1186/s12935-024-03372-8.


The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications.

Shi M, Nan X, Liu B Int J Mol Sci. 2024; 25(2).

PMID: 38256141 PMC: 10815953. DOI: 10.3390/ijms25021068.


References
1.
Attwa M, El-Etreby S . Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol. 2015; 7(12):1632-51. PMC: 4483545. DOI: 10.4254/wjh.v7.i12.1632. View

2.
Hauselmann I, Borsig L . Altered tumor-cell glycosylation promotes metastasis. Front Oncol. 2014; 4:28. PMC: 3923139. DOI: 10.3389/fonc.2014.00028. View

3.
Boye A, Yang Y . Hepatic microRNA orchestra: a new diagnostic, prognostic and theranostic tool for hepatocarcinogenesis. Mini Rev Med Chem. 2014; 14(10):837-52. View

4.
Xu X, Chen W, Miao R, Zhou Y, Wang Z, Zhang L . miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway. Oncotarget. 2015; 6(6):3988-4004. PMC: 4414168. DOI: 10.18632/oncotarget.2905. View

5.
Block T, Mehta A, Fimmel C, Jordan R . Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003; 22(33):5093-107. DOI: 10.1038/sj.onc.1206557. View